POTENT ANTITUMOR EFFICACY OF EX VIVO EXPANDED AND CRYOPRESERVED HUMAN NATURAL KILLER CELLS AGAINST ORTHOTOPIC PANCREATIC CANCER

被引：0
|
作者：
Park, G. [1 ]
Yang, B. [1 ]
Kim, E. [1 ]
Kim, H. [1 ]
Kim, Y. [1 ]
Cho, S. [1 ]
Hwang, Y. [1 ]
Min, B. [1 ]
机构：
[1] GCLabcell, Yongin, Gyeonggi Do, South Korea
来源：
CYTOTHERAPY | 2019年 / 21卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2019.03.361
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
91
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect)
    Oh, Eonju
    Min, Bokyung
    Li, Yan
    Lian, ChunYing
    Hong, JinWoo
    Park, Gyeong-min
    Yang, Bitna
    Cho, Sung Yoo
    Hwang, Yu Kyeong
    Yun, Chae-Ok
    CANCERS, 2019, 11 (07)
  • [2] Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect) (vol 11, 966, 2019)
    Oh, Eonju
    Min, Bokyung
    Lin, Yan
    Lian, ChunYing
    Hong, JinWoo
    Park, Gyeong-min
    Yang, Bitna
    Cho, Sung Yoo
    Hwang, Yu Kyeong
    Yun, Chae-Ok
    CANCERS, 2020, 12 (11)
  • [3] Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients
    Subramani, Baskar
    Pullai, Chithra Ramanathan
    Krishnan, Kohila
    Sugadan, Sheela Devi
    Deng, Xuewen
    Hiroshi, Terunuma
    Ratnavelu, Kananathan
    BIOMEDICAL REPORTS, 2014, 2 (04) : 505 - 508
  • [4] Enhanced cytotoxicity and underlying mechanism of ex vivo expanded natural killer cells against breast cancer cells
    Chen, Gege
    Wei, Rong
    Gao, Lu
    Hou, Jun
    Wu, Huiqun
    Yu, Dandan
    Zu, Weibing
    Zhang, Yiwen
    Sun, Xi
    Chang, Gaomei
    Dai, Bojie
    Tao, Yi
    Shi, Jumei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6589 - 6600
  • [5] Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells
    Keiko Kajitani
    Yuka Tanaka
    Koji Arihiro
    Tsuyoshi Kataoka
    Hideki Ohdan
    Breast Cancer Research and Treatment, 2012, 134 : 139 - 155
  • [6] Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells
    Kajitani, Keiko
    Tanaka, Yuka
    Arihiro, Koji
    Kataoka, Tsuyoshi
    Ohdan, Hideki
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 139 - 155
  • [7] Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells
    Deng, Xuewen
    Terunuma, Hiroshi
    Nieda, Mie
    Xiao, Weihua
    Nicol, Andrew
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 14 (04) : 593 - 605
  • [8] Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells
    Tina Nham
    Poznanski, Sophie M.
    Fan, Isabella Y.
    Vahedi, Fatemeh
    Shenouda, Mira M.
    Lee, Amanda J.
    Chew, Marianne V.
    Hogg, Richard T.
    Lee, Dean A.
    Ashkar, Ali A.
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (02) : 64 - 72
  • [9] Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
    Jung, Daun
    Baek, Young Seok
    Lee, In Jee
    Kim, Ki Yeon
    Jang, Heejoo
    Hwang, Sohyun
    Jung, Jieun
    Moon, Yong-wha
    Park, Kyung-Soon
    Choi, Yong-Soo
    An, Hee Jung
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [10] Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
    Daun Jung
    Young Seok Baek
    In Jee Lee
    Ki Yeon Kim
    Heejoo Jang
    Sohyun Hwang
    Jieun Jung
    Yong-wha Moon
    Kyung-Soon Park
    Yong-Soo Choi
    Hee Jung An
    Journal of Experimental & Clinical Cancer Research, 40
12345